This is the path walked through ceaseless innovation,
and the future of ORG Co., Ltd. moving forward toward the health of humanity.
-
2026- Patent granted for “Composition for Culturing Organoids and Method for Producing Organoids Using the Same”
-
2025- Unveiled a new prototype at the NextRegenX International Advanced Regenerative Medicine Exhibition.
- Received a commendation from the Mayor of Goyang in recognition of contributions to local industry development.
-
2024- Selected for the Deep Tech Track of the TIPS R&D Program Program
- Selected for the Bio i-Core Program
- Secured KRW 300 million in seed funding from Yonsei Technology Holdings.
- Filed Korean and PCT international patent applications for “Composition for Producing Cardiac Organoids”
-
2023- Confirmed as a venture business and recognized as a business-affiliated research institute.
- Selected for the Stepping Stone and Strategic Tracks of the Startup Growth Technology Development Program.
- Selected for the Early-Stage Startup Package Program
- Selected for the R&D Support Program for Women Scientists and Engineers
- Received a Merit Award at the 2023 Intellectual Property Startup Competition.
- Obtained a patent for an organoid clearing composition and filed multiple patent applications related to skin, thyroid, and kidney disease models.
- Received the Outstanding Company Growth Award at the 2023 Goyang IR Day Competition
- Won the Grand Prize at the 2023 Gyeonggi Startup Flex Competition
-
2022- Received a commendation from the Governor of Gyeonggi Province for contributions to local industry development
-
2021- Selected for the Gyeonggi Province Technology Startup Support Program
- Selected for the Gyeonggi Province Medical Device Technology Development Program
- Filed Korean and PCT international patent applications for core technologies, including an organoid clearing composition and an extracellular matrix for 3D cell culture
-
2020- Established on November 11, 2020
